- Filed
- Mar 9, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Mar 4, 2026 | 35.63M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 35.78M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2026 | 35.87M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 37.43M sh |
| Shares Diluted | Q2 2026 · Jan 31, 2025 | 37.48M sh |
| Stock Repurchased | Q2 2026 · Jan 31, 2026 | $45M |
| Stock Repurchased | Q2 2026 · Jan 31, 2026 | $45M |
| Stock Repurchased | Q2 2026 · Jan 31, 2025 | $20M |
| Stock Repurchased | Q2 2026 · Jan 31, 2025 | $40M |
| Dividends Paid | Q2 2026 · Jan 31, 2026 | $158.92M |
| Dividends Paid | Q2 2026 · Jan 31, 2025 | $165.97M |
| Capex | Q2 2026 · Jan 31, 2026 | $146.58M |
| Capex | Q2 2026 · Jan 31, 2025 | $146.03M |
| Operating Cash Flow | Q2 2026 · Jan 31, 2026 | $575.85M |
| Operating Cash Flow restated | Q2 2026 · Jan 31, 2025 | $609.17M |
| Cash And Equivalents | Q2 2026 · Jan 31, 2026 | $384.74M |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $440.29M |
| Cash And Equivalents | Q2 2026 · Jan 31, 2025 | $488.21M |
| Stockholders Equity | Q2 2026 · Jan 31, 2026 | $301.82M |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $424.5M |
| Stockholders Equity restated | Q2 2026 · Jan 31, 2025 | $515.51M |
| Current Liabilities | Q2 2026 · Jan 31, 2026 | $1.32B |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $1.67B |
| Current Liabilities restated | Q2 2026 · Jan 31, 2025 | $1.78B |
| Total Liabilities | Q2 2026 · Jan 31, 2026 | $4.96B |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $5.02B |
| Total Liabilities restated | Q2 2026 · Jan 31, 2025 | $4.72B |
| Current Assets | Q2 2026 · Jan 31, 2026 | $822.72M |
| Current Assets | Q2 2026 · Jul 31, 2025 | $1.05B |
| Current Assets restated | Q2 2026 · Jan 31, 2025 | $838.47M |
| Total Assets | Q2 2026 · Jan 31, 2026 | $5.6B |
| Total Assets | Q2 2026 · Jul 31, 2025 | $5.78B |
| Total Assets restated | Q2 2026 · Jan 31, 2025 | $5.52B |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $5.87 |
| Eps Diluted | Q2 2026 · Jan 31, 2026 | $0.65 |
| Eps Diluted restated | Q2 2026 · Jan 31, 2025 | $6.53 |
| Eps Diluted restated | Q2 2026 · Jan 31, 2025 | $1.90 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $5.87 |
| Eps Basic | Q2 2026 · Jan 31, 2026 | $0.65 |
| Eps Basic restated | Q2 2026 · Jan 31, 2025 | $6.54 |
| Eps Basic restated | Q2 2026 · Jan 31, 2025 | $1.90 |
| Net Income | Q2 2026 · Jan 31, 2026 | $210.01M |
| Net Income | Q2 2026 · Jan 31, 2026 | $23.26M |
| Net Income restated | Q2 2026 · Jan 31, 2025 | $244.38M |
| Net Income restated | Q2 2026 · Jan 31, 2025 | $71.12M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $345.05M |
| Operating Income | Q2 2026 · Jan 31, 2026 | $135.23M |
| Operating Income restated | Q2 2026 · Jan 31, 2025 | $383.17M |
| Operating Income restated | Q2 2026 · Jan 31, 2025 | $181.24M |
| Revenue | Q2 2026 · Jan 31, 2026 | $1.08B |
| Revenue | Q2 2026 · Jan 31, 2026 | $1.35B |
| Revenue | Q2 2026 · Jan 31, 2025 | $1.14B |
| Revenue | Q2 2026 · Jan 31, 2025 | $1.4B |